Regulation & Compliance

Luna Federici, the architect of PicnicHealth's recent growth, takes the helm as President to scale the company's patient-first, AI-powered research model.

Verifiable's new CredAgent™ promises to slash credentialing times and costs, challenging the industry's reliance on manual labor and offshore outsourcing.

Panorama Education launches AI-powered tutoring and career tools, promising personalized student support while navigating the complex landscape of data privacy.

With a massive new investment led by NewSpring, physician-led Honest Health is set to expand its mission of transforming healthcare from volume to value.

Onramper integrates Payward Ramp, giving its partners access to Kraken's deep liquidity and compliance engine, drastically simplifying fiat-to-crypto payments.

The 401(k) provider hires sales and regulatory leaders to capitalize on surging demand from small businesses and navigate complex new retirement laws.

A new partnership brings AI to customs, promising to help U.S. importers reclaim millions in overpaid duties and navigate volatile global trade.

CentFX won a top broker award but faces scrutiny as it launches a payment card and crypto token. Can it build a trusted fintech ecosystem or will it buckle?

Nuveen Churchill Direct Lending Corp. adjusts its shareholder return strategy in response to a changing interest rate and spread environment.

With promising data for its oral STAT6 degrader and a cash runway into 2029, Kymera Therapeutics is poised to disrupt the injectable-dominated market.

After a massive divestiture, Vistance Networks reports soaring growth, zero debt, and plans a huge special cash distribution to its shareholders.

With a key FDA decision looming and pivotal data on a second therapy imminent, Viridian is poised to reshape the multi-billion dollar Thyroid Eye Disease market.

After a strong 2025, Viatris unveils a plan for $650M in savings, a 10% workforce cut, and a focus on six new drugs to fuel future innovation.

Perrigo takes a massive $1.3B impairment charge and plans a 7% workforce reduction as it pivots to a 'CORE' business amid a challenging outlook.

Geneva's CBH Group reports a 13% surge in assets to CHF 18.4B, fueled by strategic investments and a capital ratio that towers over industry peers.

DelphX Capital Markets raises fresh capital for its innovative structured notes, navigating weak financials and a competitive market for hybrid securities.

Intapp's new agentic AI platform, Celeste, promises to automate complex workflows while enforcing strict compliance, tackling AI's biggest hurdle in regulated industries.

MiMedx reports record 2025 sales and a $100M buyback, but faces a major challenge from new Medicare reimbursement rules set to disrupt the wound care market.

With a massive late-stage pipeline and deep pockets, the biotech aims to defeat elusive cancer targets, but soaring costs raise the stakes for pivotal trials.

The Kentucky Derby operator posts record revenue and operational earnings, yet a 28% drop in quarterly net income reveals a complex story of growth and challenges.